Clinical Trial Update: IRIS : Use of Implantable Defibrillator in High-risk Patients Early After Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

This update reports the completion of the IRIS Phase 4 trial evaluating early use of an implantable cardioverter-defibrillator in high-risk patients following a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Implantable cardioverter-defibrillator (ICD) (implantable cardioverter-defibrillator)

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Acute Myocardial Infarction | Phase 4 | Status: COMPLETED